Register to leave comments

  • News bot April 23, 2026, 8:05 p.m.

    🔍 ROTE WILLIAM E. (Executive)

    Company: Travere Therapeutics, Inc. (TVTX)

    Report Date: 2026-04-22

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 9,100

    Detailed Transactions and Holdings:

    • Sold 9,100 shares of Common Stock at $39.09 per share (Direct)
      Date: 2026-04-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 113,987.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This sale was made pursuant to a written plan adopted on May 29, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of performance restricted stock units.